New inhaled antibody tested in humans for first time
Knowledge-focused
Not yet recruiting
This early-stage trial will test the safety and how the body handles an inhaled antibody called TRL1068 in 14 healthy volunteers. Participants will receive either the drug or a placebo through a nebulizer. The study aims to gather initial safety data and does not target any speci…
Phase: PHASE1 • Sponsor: Trellis Bioscience LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC